The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Vimentin Intermediate Filaments as Potential Target for Cancer Treatment
Open accessAbstract
Intermediate filaments constitute the third component of the cellular skeleton. Unlike actin and microtubule cytoskeletons, the intermediate filaments are composed of a wide variety of structurally related proteins showing distinct expression patterns in tissues and cell types. Changes in the expression patterns of intermediate filaments are often associated with cancer progression; in particular with phenotypes leading to increased cellular migration and invasion. In this review we will describe the role of vimentin intermediate filaments in cancer cell migration, cell adhesion structures, and metastasis formation. The potential for targeting vimentin in cancer treatment and the development of drugs targeting vimentin will be reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin
Zhang, J., Liu, D., Feng, Z., Mao, J., Zhang, C., Lü, Y., Li, J., Zhang, Q., Li, Q., & Li, L. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.018 · Cited by 98
RetractedCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Vimentin in cancer and its potential as a molecular target for cancer therapy
Satelli, A., & Li, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0735-1 · Cited by 1,557
Mendez, M. G., Kojima, S., & Goldman, R. D. (2010) · The FASEB Journal · doi:10.1096/fj.09-151639 · Cited by 939
BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
Steegmaier, M., Hoffmann, M., Baum, A., Lénárt, P., Petronczki, M., Krššák, M., Gürtler, U., Garin-Chesa, P., Lieb, S., Quant, J., et al. (2007) · Current Biology · doi:10.1016/j.cub.2006.12.037 · Cited by 834
Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011) · Oncogene · doi:10.1038/onc.2010.509 · Cited by 647
Transforming Growth Factor β-1 Induces Snail Transcription Factor in Epithelial Cell Lines
Peinado, H., Quintanilla, M., & Cano, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211304200 · Cited by 642
Mice lacking vimentin develop and reproduce without an obvious phenotype
Colucci-Guyon, E., Portier, M.-M., Dunia, I., Paulin, D., Pournin, S., & Babinet, C. (1994) · Cell · doi:10.1016/0092-8674(94)90553-3 · Cited by 598
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.32 · Cited by 541
Cited by
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
Ding, Y., Lv, C., Zhou, Y., Zhang, H., Zhao, L., Xu, Y., & Fan, X. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112666 · Cited by 21
Li, J., Zhou, Z., Zhang, J., Wang, M., Luan, X., Zhao, M., Jiang, G., Wang, G., Li, S., Xiang, W., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03618-5 · Cited by 8
Metadata
- Authors
- Strouhalova, K., Přechová, M., Gandalovičová, A., Brábek, J., Gregor, M., & Rosel, D.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2020-01-11
- Volume
- 12
- Issue
- 1
- Pages
- 184
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3000307676
- Cited by
- 255
- References
- 130
- FWCI
- 17.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vimentin Intermediate Filaments as Potential Target for Cancer Treatment. https://app.cochat.ai/papers/10.3390/cancers12010184
- The paper
- Strouhalova, K., Přechová, M., Gandalovičová, A., Brábek, J., Gregor, M., & Rosel, D. (2020). Vimentin Intermediate Filaments as Potential Target for Cancer Treatment. Cancers. https://doi.org/10.3390/cancers12010184
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.